UPLOAD Filing
Cellectis S.A.
Date: July 7, 2025 · CIK: 0001627281 · Accession: 0000000000-25-007093
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288491
Letter
Re: Cellectis S.A. Registration Statement on Form F-3 Filed July 2, 2025 File No. 333-288491 Dear Andr Choulika:
July 7, 2025
Andr Choulika Chief Executive Officer Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Peter E. Devlin, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 7, 2025 Andr Choulika Chief Executive Officer Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France Re: Cellectis S.A. Registration Statement on Form F-3 Filed July 2, 2025 File No. 333-288491 Dear Andr Choulika: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Peter E. Devlin, Esq. </TEXT> </DOCUMENT>